8.410USD+4.08%Mkt Cap: 549.38M USDP/E: —Last update: 2026-05-22
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell en…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap549.38M USD
Enterprise Value565.07M USD
Revenue (TTM)151.40M USD
Gross Profit123.18M USD
Net Income (TTM)-312.76M USD
Revenue/Share2.666 USD
Last Price8.410 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees485
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.52
PEG—
EV/EBITDA-2.15
EV/Revenue3.73
P/S3.49
P/B1.12
EPS (TTM)-5.38
EPS (Forward)-3.21
52W Range
5.37025% of range17.58
52W High17.58 USD
52W Low5.370 USD
Profitability
Gross Margin72.39%
Oper. Margin-366.51%
EBITDA Margin-173.38%
Profit Margin-183.81%
ROE-61.50%
ROA-27.93%
Growth
Revenue Growth-49.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-171.06M USD
CapEx (TTM)7.67M USD
FCF Margin-51.47%
FCF Yield-14.19%
Net Debt37.24M USD
Net Debt/EBITDA-0.14
Balance Sheet
Debt/Equity0.86
Current Ratio5.15
Quick Ratio4.95
Book Value/Sh7.187 USD
Cash/Share5.717 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateAug 20, 2024
Analyst Consensus
Rating3.3 (Hold)
Target (Mean)8.500 USD
Target Range5.000 USD – 12.00 USD
# Analysts2
Ownership
Shares Out.53.36M
Float47.71M
Insiders4.60%
Institutions68.71%
Short Interest
Short Ratio4.7d
Short % Float10.14%
Short % Out.8.01%
Shares Short5.23M
Short (prev mo.)6.15M
Technical
SMA 507.597 (+10.7%)
SMA 2009.747 (-13.7%)
Beta1.78
S&P 52W Chg28.31%
Avg Vol (30d)1.26M
Avg Vol (10d)1.17M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—